Visit Us @
Synergy Centre TU Dublin, Tallaght, D24A386
Mail Us @
info@codlad.com
Call Us @
+353 851890752

FDA

FDA In Brief: As Consumers Order More Meals and Groceries Online, FDA Plans Public Meeting to Address Food Safety Risks

September 9, 2021

FDA In Brief: As Consumers Order More Meals and Groceries Online, FDA Plans Public Meeting to Address Food Safety Risks

The following quote is attributed to Frank Yiannas, Deputy Commissioner for Food Policy and Response “The COVID-19 pandemic has accelerated the need for the FDA…

FDA In Brief: As Consumers Order More Meals and Groceries Online, FDA Plans Public Meeting to Address Food Safety Risks FDA
FDA In Brief: FDA Announces Public Workshop to Reconsider Mandatory Prescriber Education for Opioids

September 8, 2021

FDA In Brief: FDA Announces Public Workshop to Reconsider Mandatory Prescriber Education for Opioids

The following quote is attributed to Patrizia Cavazzoni, M.D., director of the FDA’s Center for Drug Evaluation and Research “The opioid crisis continues to evolve…

FDA In Brief: FDA Announces Public Workshop to Reconsider Mandatory Prescriber Education for Opioids FDA
Coronavirus (COVID-19) Update: September 7, 2021

September 7, 2021

Coronavirus (COVID-19) Update: September 7, 2021

The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic: As part of the…

Coronavirus (COVID-19) Update: September 7, 2021 FDA
FDA In Brief: FDA Reaches Milestone in Competitive Generic Therapy Drug Approvals

September 2, 2021

FDA In Brief: FDA Reaches Milestone in Competitive Generic Therapy Drug Approvals

The following quote is attributed to Sally Choe, Ph.D., director of the Office of Generic Drugs in the FDA’s Center for Drug Evaluation and Research…

FDA In Brief: FDA Reaches Milestone in Competitive Generic Therapy Drug Approvals FDA
FDA In Brief: FDA to Hold Advisory Committee Meeting to Discuss Pfizer-BioNTech’s Application for COVID-19 Booster

September 1, 2021

FDA In Brief: FDA to Hold Advisory Committee Meeting to Discuss Pfizer-BioNTech’s Application for COVID-19 Booster

The following quote is attributed to Peter Marks, M.D., Ph.D., director of the FDA’s Center for Biologics Research and Evaluation: “The administration recently announced a…

FDA In Brief: FDA to Hold Advisory Committee Meeting to Discuss Pfizer-BioNTech’s Application for COVID-19 Booster FDA
Coronavirus (COVID-19) Update: August 31, 2021

August 31, 2021

Coronavirus (COVID-19) Update: August 31, 2021

The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic: On August 27, the…

Coronavirus (COVID-19) Update: August 31, 2021 FDA
Coronavirus (COVID-19) Update: August 27, 2021

August 27, 2021

Coronavirus (COVID-19) Update: August 27, 2021

The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic: On August 25, the…

Coronavirus (COVID-19) Update: August 27, 2021 FDA
FDA Approves First-of-Its-Kind Stroke Rehabilitation System

August 27, 2021

FDA Approves First-of-Its-Kind Stroke Rehabilitation System

The U.S. Food and Drug Administration today approved the MicroTransponder Vivistim Paired VNS System (Vivistim System), a first-of-its-kind, drug-free rehabilitation system intended to treat moderate…

FDA Approves First-of-Its-Kind Stroke Rehabilitation System FDA
FDA Denies Marketing Applications for About 55,000 Flavored E-Cigarette Products for Failing to Provide Evidence They Appropriately Protect Public Health

August 26, 2021

FDA Denies Marketing Applications for About 55,000 Flavored E-Cigarette Products for Failing to Provide Evidence They Appropriately Protect Public Health

Today, the U.S. Food and Drug Administration issued the first marketing denial orders (MDOs) for electronic nicotine delivery system (ENDS) products after determining the applications…

FDA Denies Marketing Applications for About 55,000 Flavored E-Cigarette Products for Failing to Provide Evidence They Appropriately Protect Public Health FDA
FDA Releases PFAS Testing Results from First Survey of Nationally Distributed Processed Foods

August 26, 2021

FDA Releases PFAS Testing Results from First Survey of Nationally Distributed Processed Foods

Today, the U.S. Food and Drug Administration released the results of the first survey of per- and polyfluoroalkyl substances (PFAS) in nationally distributed processed foods,…

FDA Releases PFAS Testing Results from First Survey of Nationally Distributed Processed Foods FDA

Latest Posts

FDA Moves to Accelerate Biosimilar Development and Lower Drug Costs
FDA Moves to Accelerate Biosimilar Development and Lower Drug Costs
October 29, 2025
FDA Issues Emergency Use Authorization for New World Screwworm Drug for Dogs
FDA Issues Emergency Use Authorization for New World Screwworm Drug for Dogs
October 24, 2025
FDA Publishes Filing Checklists to Prevent Submission Delays
FDA Publishes Filing Checklists to Prevent Submission Delays
October 23, 2025